Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.

Article  PubMed  Google Scholar 

Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.

Article  CAS  PubMed  Google Scholar 

Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC. Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994;152(1):115–9.

Article  CAS  PubMed  Google Scholar 

Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016;2:16031.

Article  PubMed  Google Scholar 

Afari N, Gasperi M, Forsberg CW, Goldberg J, Buchwald D, Krieger JN. Heritability of lower urinary tract symptoms in men: a twin study. J Urol. 2016;196(5):1486–92.

Article  PubMed  PubMed Central  Google Scholar 

Hellwege JN, Stallings S, Torstenson ES, Carroll R, Borthwick KM, Brilliant MH, Crosslin D, Gordon A, Hripcsak G, Jarvik GP, et al. Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. Sci Rep. 2019;9(1):6077.

Article  PubMed  PubMed Central  Google Scholar 

Chen ZP, Yan Y, Chen CJ, Li M, Chen C, Zhao SC, Song T, Liu T, Zou CH, Xu Q, et al. The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH). Andrology. 2018;6(4):568–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruan L, Zhu JG, Pan C, Hua X, Yuan DB, Li ZM, Zhong WD. Association between single nucleotide polymorphism of vitamin D receptor gene FokI polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal 2015, 2015:235895.

Tang J, Yang J. Etiopathogenesis of benign prostatic hypeprlasia. Indian J Urol. 2009;25(3):312–7.

Article  PubMed  PubMed Central  Google Scholar 

Jiao Y, Wang L, Gu X, Tao S, Tian L, Na R, Chen Z, Kang J, Zheng SL, Xu J, et al. LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population. Int J Mol Sci. 2013;14(5):8832–40.

Article  PubMed  PubMed Central  Google Scholar 

Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Kim D, Kim HJ, Myung SC. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population. Gene. 2014;533(1):86–93.

Article  CAS  PubMed  Google Scholar 

Tanigawa Y, Qian J, Venkataraman G, Justesen JM, Li R, Tibshirani R, Hastie T, Rivas MA. Significant sparse polygenic risk scores across 813 traits in UK Biobank. PLoS Genet. 2022;18(3):e1010105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Privé F, Aschard H, Carmi S, Folkersen L, Hoggart C, O’Reilly PF, Vilhjálmsson BJ. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am J Hum Genet. 2022;109(1):12–23.

Article  PubMed  PubMed Central  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.

Article  PubMed  PubMed Central  Google Scholar 

Michel MC, Vrydag W. Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol. 2006;147(Suppl 2):S88–119.

CAS  PubMed  PubMed Central  Google Scholar 

McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr., Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr., Clarke HS, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98.

Article  CAS  PubMed  Google Scholar 

Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, Montorsi F. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008;179(2):616–21. discussion 621.

Article  CAS  PubMed  Google Scholar 

Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123–31.

Article  CAS  PubMed  Google Scholar 

Bruce A, Krishan A, Sadiq S, Ehsanullah SA, Khashaba S. Safety and Efficacy of Bipolar Transurethral Resection of the prostate vs monopolar transurethral resection of prostate in the treatment of moderate-large volume Prostatic Hyperplasia: a systematic review and Meta-analysis. J Endourol. 2021;35(5):663–73.

Article  PubMed  Google Scholar 

Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19(9):581–90.

Article  CAS  PubMed  Google Scholar 

Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12(1):44.

Article  PubMed  PubMed Central  Google Scholar 

Tamlander M, Mars N, Pirinen M, Widén E, Ripatti S. Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes. Commun Biol. 2022;5(1):158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xin J, Jiang X, Li H, Chen S, Zhang Z, Wang M, Gu D, Du M, Christiani DC. Prognostic evaluation of polygenic risk score underlying pan-cancer analysis: evidence from two large-scale cohorts. EBioMedicine. 2023;89:104454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gudmundsson J, Sigurdsson JK, Stefansdottir L, Agnarsson BA, Isaksson HJ, Stefansson OA, Gudjonsson SA, Gudbjartsson DF, Masson G, Frigge ML, et al. Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. Nat Commun. 2018;9(1):4568.

Article  PubMed  PubMed Central  Google Scholar 

Fan CT, Lin JC, Lee CH. Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics. 2008;9(2):235–46.

Article  PubMed  Google Scholar 

Wei CY, Yang JH, Yeh EC, Tsai MF, Kao HJ, Lo CZ, Chang LP, Lin WJ, Hsieh FJ, Belsare S, et al. Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. NPJ Genom Med. 2021;6(1):10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48(10):1284–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.

Article  PubMed  Google Scholar 

Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O’Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.

Article  PubMed  PubMed Central  Google Scholar 

Prive F, Vilhjalmsson BJ, Aschard H, Blum MGB. Making the most of clumping and thresholding for polygenic scores. Am J Hum Genet. 2019;105(6):1213–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marees AT, de Kluiver H, Stringer S, Vorspan F, Curis E, Marie-Claire C, Derks EM. A tutorial on conducting genome-wide association studies: quality control and statistical analysis. Int J Methods Psychiatr Res. 2018;27(2):e1608.

Article  PubMed  PubMed Central  Google Scholar 

Lambert SA, Gil L, Jupp S, Ritchie SC, Xu Y, Buniello A, McMahon A, Abraham G, Chapman M, Parkinson H, et al. The polygenic score catalog as an open database for reproducibility and systematic evaluation. Nat Genet. 2021;53(4):420–5.

Article  CAS  PubMed  Google Scholar 

Collister JA, Liu X, Clifton L. Calculating polygenic risk scores (PRS) in UK Biobank: a practical guide for epidemiologists. Front Genet. 2022;13:818574.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC. Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology. 1994;44(5):646–50.

Article